MFIM
AZN icon

Mesirow Financial Investment Management’s AstraZeneca AZN Stock Holding History

Mesirow Financial Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Sell
1,953
-230
-11% -$43.3K 0.01% 410
2026
Q1 		$431K Buy
2,183
+495
+29% +$95.4K 0.01% 376
2025
Q4 		$310K Sell
1,688
-2,888
-63% -$507K 0.01% 398
2025
Q3 		$702K Buy
4,576
+408
+10% +$61.8K 0.01% 316
2025
Q2 		$583K Sell
4,168
-1,349
-24% -$189K 0.01% 335
2025
Q1 		$811K Sell
5,517
-190
-3% -$27.5K 0.02% 284
2024
Q4 		$748K Buy
5,707
+398
+7% +$55.7K 0.01% 298
2024
Q3 		$827K Buy
5,309
+326
+7% +$52.6K 0.02% 289
2024
Q2 		$778K Sell
4,983
-221
-4% -$33.3K 0.02% 276
2024
Q1 		$705K Buy
5,204
+615
+13% +$81.4K 0.02% 298
2023
Q4 		$618K Buy
+4,589
New +$597K 0.02% 281

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mesirow Financial Investment Management's AZN Position: Q2 2026 in Review

Mesirow Financial Investment Management reduced its AstraZeneca (AZN) stake by 11% in Q2 2026, selling an estimated $43.3K and leaving 1,953 shares worth $370K. The position accounts for 0.01% of the portfolio, ranked #410.

Mesirow Financial Investment Management first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $827K in Q3 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Mesirow Financial Investment Management held 1,953 shares of AstraZeneca worth $370K as of Q2 2026.
  • Mesirow Financial Investment Management sold 230 AstraZeneca shares in Q2 2026, an estimated $43.3K.
  • AstraZeneca made up 0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #410 holding.
  • Mesirow Financial Investment Management first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's AstraZeneca position peaked at $827K in Q3 2024.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.